THYE DIRK (Chief Executive Officer) purchased 22.4% of their position (154.50K shares) of QUINCE THERAPEUTICS, INC. on the open market
Open‑market purchase worth $107.4K — a significant purchase. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 9/3/2024ACC: 0001415889-24-022702
DirectorOfficer· Chief Executive Officer
Since May 2022
+154.50K
Net shares
Net buyer
$107.4K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
154.50K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+77.50K
Price / share
$0.69
Trade value
$53.47K
% of position
11.2%
8/29/2024
689.44K→766.94K
Common Stock
Direct
Shares
+77K
Price / share
$0.70
Trade value
$53.90K
% of position
10.0%
8/30/2024
766.94K→843.94K
Total
Net shares
+154.50K
Net value
$107.38K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/29/2024 | P · Purchase | +77.50K | $0.69 | $53.47K | 11.2% | 689.44K | 766.94K |
| Common Stock Direct | 8/30/2024 | P · Purchase | +77K | $0.70 | $53.90K | 10.0% | 766.94K | 843.94K |
| Total | +154.50K | $107.38K | ||||||
Derivative Transactions0
No derivative transactions reported